US EditionImricor wins European assent for its world-leading heart tool
Summary by Stockhead
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Imricor wins European assent for its world-leading heart tool
Imricor receives CE Mark certification for the Advantage-MR system under new European Medical Device Regulation Approval follows CE Mark certification for the second-generation Vision-MR Ablation Catheter in February Imricor recently started its European clinical trial known as VISABL-VT, achieving several world firsts Special Report: Imricor Medical Systems has secured CE Mark certification for its Advantage-MR system under the European Unio…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
